| 4.97 -0.23 (-4.42%) | 06-26 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.5 | 1-year : | 6.42 |
| Resists | First : | 4.71 | Second : | 5.5 |
| Pivot price | 0 | |||
| Supports | First : | 4.5 | Second : | 4.38 |
| MAs | MA(5) : | 0 | MA(20) : | 0 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0 | Signal : | 0 |
| %K %D | K(14,3) : | 0 | D(3) : | 0 |
| RSI | RSI(14): 0 | |||
| 52-week | High : | 4.71 | Low : | 4.38 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NITO ] has closed Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Nexentis Technologies Inc. develops and operates an AI and data-driven computational biotech platform. It focuses on mitochondrial biology, precision oncology, and inflammatory metabolic diseases. The company biotechnology segment, driven by its proprietary MITOLINE discovery engine and structure-guided virtual screening workflows, is engaged in the discovery and development of small-molecule therapeutics targeting the mitochondrial SLC25 carrier family for resistant cancers and inflammatory metabolic disease indications. The company’s pipeline includes preclinical programs for oncology and metabolic-inflammation, with evidence supporting anti-tumor and anti-inflammatory activity in human-relevant systems. The renewable energy investments segment manages non-core, value-optimizing assets, including investments in solar energy projects across multiple european union countries, utilizing a ready to build business model. In addition, the company provides post-harvest treatment technologies for reducing pathogen contamination in fruits and vegetables. It serves customers in the biotechnology, pharmaceutical, and renewable energy sectors, as well as the agricultural industry. The company operates internationally, with a particular focus on the European Union and Israel. The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel.
Thu, 25 Jun 2026
N2OFF Inc (NITO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Thu, 18 Jun 2026
N2OFF Inc (NITO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Thu, 18 Jun 2026
N2OFF Inc (NITO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Wed, 17 Jun 2026
N2OFF Inc (NITO) Institutional Confidence - TradingKey
Mon, 06 Apr 2026
Nexentis Technologies (NITO) enacts 1-for-7 reverse stock split, cuts share count - Stock Titan
Wed, 25 Feb 2026
N2OFF Announcing Corporate Rebranding as Nexentis - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|